Beijing Sinocro Pharma Science

Beijing Sinocro Pharmaceutical Science & Technology (Sinocro) is a leading Chinese Contract Research Organization (CRO) providing comprehensive clinical development services to the pharmaceutical and medical device industries. Founded in 2007 and headquartered in Beijing, the company specializes in clinical trial management, regulatory affairs, data management, and biostatistics. Sinocro is widely recognized for its expertise in navigating the Chinese regulatory landscape (NMPA) and has supported numerous domestic and international clients in bringing products to market. In July 2020, the company was acquired by ClinChoice (formerly Fountain Medical Development), a global CRO, to strengthen its clinical operations and regulatory capabilities within the Asia-Pacific region. The integration allows Sinocro to leverage a global service platform while maintaining its specialized focus on the Chinese market.